Treatment and prognosis for breast cancer have historically been determined by the presence or lack of particular molecular markers, such as the HER2 protein, progesterone receptors (PR), and estrogen receptors (ER) [52,53,54]. Here, ERBB2 is linked to breast carcinoma.